Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarnow

Showing results (571-580 of 848) with videos related to

Pageof 85
Sort By:
Journal of Medicinal Chemistry|October 1, 1983
Mitomycin C analogues with secondary amines at position 7B S Iyengar, S M Sami, S E Tarnow, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 29, 2016
Integration of EEG Into Psychiatric Practice: A Step Toward Precision Medicine for Autism Spectrum DisorderRonald J Swatzyna, Jay D Tarnow, Robert P Turner, et al.
The International Journal of Oral & Maxillofacial Implants|June 20, 2003
A prospective multicenter clinical trial of 3i machined-surface implants: results after 6 years of follow-upDietmar Weng, Zhimon Jacobson, Dennis Tarnow, et al.
European Journal of Endocrinology|January 2, 2008
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetesSøren S Lund, Lise Tarnow, Merete Frandsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) studyFrederik Persson, Peter Rossing, Peter Hovind, et al.
Endocrinology|July 14, 2007
Evolutionary aspects in evaluating mutations in the melanocortin 4 receptorClaudia Stäubert, Patrick Tarnow, Harald Brumm, et al.
Diabetes Technology & Therapeutics|June 12, 2014
Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemiaZeinab Mahmoudi, Morten Hasselstrøm Jensen, Mette Dencker Johansen, et al.
Ugeskrift for Laeger|September 10, 2010
[Reporting adverse reactions and events in randomised clinical trials]Bianca Hemmingsen, Lina Støy, Jørn Wetterslev, et al.
BMJ (Clinical Research Ed.)|April 21, 2004
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort studyPeter Hovind, Lise Tarnow, Peter Rossing, et al.
Diabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.
Pageof 85

Showing results (571-580 of 848) with videos related to

Sort By:
Pageof 85
Journal of Medicinal Chemistry|October 1, 1983
Mitomycin C analogues with secondary amines at position 7B S Iyengar, S M Sami, S E Tarnow, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 29, 2016
Integration of EEG Into Psychiatric Practice: A Step Toward Precision Medicine for Autism Spectrum DisorderRonald J Swatzyna, Jay D Tarnow, Robert P Turner, et al.
The International Journal of Oral & Maxillofacial Implants|June 20, 2003
A prospective multicenter clinical trial of 3i machined-surface implants: results after 6 years of follow-upDietmar Weng, Zhimon Jacobson, Dennis Tarnow, et al.
European Journal of Endocrinology|January 2, 2008
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetesSøren S Lund, Lise Tarnow, Merete Frandsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) studyFrederik Persson, Peter Rossing, Peter Hovind, et al.
Endocrinology|July 14, 2007
Evolutionary aspects in evaluating mutations in the melanocortin 4 receptorClaudia Stäubert, Patrick Tarnow, Harald Brumm, et al.
Diabetes Technology & Therapeutics|June 12, 2014
Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemiaZeinab Mahmoudi, Morten Hasselstrøm Jensen, Mette Dencker Johansen, et al.
Ugeskrift for Laeger|September 10, 2010
[Reporting adverse reactions and events in randomised clinical trials]Bianca Hemmingsen, Lina Støy, Jørn Wetterslev, et al.
BMJ (Clinical Research Ed.)|April 21, 2004
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort studyPeter Hovind, Lise Tarnow, Peter Rossing, et al.
Diabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.
Pageof 85